Brand against brand · semaglutide and tirzepatide

Ozempic vs Mounjaro

From the two FDA labels, read Published by PepVault

Ozempic is semaglutide, a GLP-1 receptor agonist, from Novo Nordisk; Mounjaro is tirzepatide, a GIP and GLP-1 receptor agonist, from Eli Lilly.

FDA approved Ozempic for blood sugar control in adults with type 2 diabetes, and lowering heart and kidney risks in some of them. Mounjaro is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes.

Label against label

Ozempic and Mounjaro, from their FDA labels and Drugs@FDA
ComparedOzempicMounjaro
Active ingredientsemaglutidetirzepatide
ClassGLP-1 receptor agonistGIP and GLP-1 receptor agonist
MakerNovo NordiskEli Lilly
Approved forType 2 diabetes; heart and kidney risk in type 2 diabetesType 2 diabetes (adults and children 10 and up); heart risk
FormsMulti-dose pen; Single-dose prefilled syringe; TabletSingle-dose pen or vial; Multi-dose vial or KwikPen
How oftenonce a week or once a dayonce a week
Starting dose0.25 mg a week (injection); 1.5 mg a day (tablets)2.5 mg a week
Top dose on the label2 mg a week (injection); 9 mg a day (tablets)15 mg a week
Most reported side effectNausea, 20.3% on 1 mg (placebo 6.1%)Nausea, 18% on 15 mg (placebo 4%)
Boxed warning“RISK OF THYROID C-CELL TUMORS”“RISK OF THYROID C-CELL TUMORS”
First approved20172022

Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.

The two dosing schedules

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

Ozempic injection, once a week

0.25 mg0.5 mg1 mgif needed2 mgif needed
Ozempic’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Ozempic tablets, once a day

1.5 mg4 mg9 mgif needed
Ozempic’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Mounjaro, once a week

2.5 mg5 mgif needed7.5 mgif needed10 mgif needed12.5 mgif needed15 mgif needed
Mounjaro’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.
A smiling woman in a dark training top in her kitchen, holding a glass of water

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

A missed dose, on each label

  • Ozempic: A missed weekly injection is taken as soon as possible within 5 days. Past 5 days, the label skips it and the next dose comes on the usual day.
  • Mounjaro: A missed Mounjaro dose can still be given within 4 days (96 hours). After that it is skipped and the next one comes on the usual day.

The trial evidence

Questions

What is the difference between Ozempic and Mounjaro?

Ozempic is semaglutide, a GLP-1 receptor agonist; Mounjaro is tirzepatide, a GIP and GLP-1 receptor agonist. Their labels approve them for different uses and set different schedules.

What are Ozempic and Mounjaro approved for?

Ozempic is approved for blood sugar control in adults with type 2 diabetes, and lowering heart and kidney risks in some of them. Mounjaro is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes.

How often are Ozempic and Mounjaro taken?

Ozempic is taken once a week or once a day, as an injection or a tablet; Mounjaro once a week, as an injection.

What are the dose ranges of Ozempic and Mounjaro?

On their labels, Ozempic runs 0.25 mg to 2 mg once a week or 1.5 mg to 9 mg once a day, and Mounjaro 2.5 mg to 15 mg once a week. A prescriber sets the actual dose.

What is the most common side effect of Ozempic and Mounjaro?

On Ozempic’s label: nausea, 20.3% on 1 mg (placebo 6.1%). On Mounjaro’s: nausea, 18% on 15 mg (placebo 4%).

Sources

PepVault is not affiliated with Novo Nordisk. Ozempic is a trademark of its owner. PepVault is not affiliated with Eli Lilly. Mounjaro is a trademark of its owner.

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo